We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Erlotinib and Sequential Positron Emission Tomography (PET) in Advanced Non Small Cell Lung Cancer (NSCLC) (ERLOPET)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00568841
Recruitment Status : Unknown
Verified September 2009 by Lung Cancer Group Cologne.
Recruitment status was:  Active, not recruiting
First Posted : December 6, 2007
Last Update Posted : September 17, 2009
Sponsor:
Information provided by: